These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
239 related items for PubMed ID: 33547762
1. The Rh blood group system and its role in alloimmunization rate among sickle cell disease and sickle thalassemia patients in Iran. Jalali Far MA, Oodi A, Amirizadeh N, Mohammadipour M, Keikhaei Dehdezi B. Mol Genet Genomic Med; 2021 Mar; 9(3):e1614. PubMed ID: 33547762 [Abstract] [Full Text] [Related]
2. The value of transfusion of phenotyped blood units for thalassemia and sickle cell anemia patients at an academic center. Hindawi S, Badawi M, Elfayoumi R, Elgemmezi T, Al Hassani A, Raml M, Alamoudi S, Gholam K. Transfusion; 2020 Feb; 60 Suppl 1():S15-S21. PubMed ID: 32134130 [Abstract] [Full Text] [Related]
3. Alloimmunization in transfused patients with constitutional anemias in Norway. Furuseth MT, Alme C, Garvik LJ, Hellebostad M, Bechensteen AG, Akkök ÇA. Transfus Apher Sci; 2021 Oct; 60(5):103257. PubMed ID: 34420880 [Abstract] [Full Text] [Related]
4. Predicting the effect of transfusing only phenotype-matched RBCs to patients with sickle cell disease: theoretical and practical implications. Castro O, Sandler SG, Houston-Yu P, Rana S. Transfusion; 2002 Jun; 42(6):684-90. PubMed ID: 12147019 [Abstract] [Full Text] [Related]
5. Molecular genotyping versus serological diagnosis for RH blood group typing in sickle cell patients. Eftekhar Z, Oodi A, Amirizadeh N, Mohammadipour M, Keikhaei Dehdezi B, Jalali Far MA. Expert Rev Clin Immunol; 2024 Nov; 20(11):1421-1426. PubMed ID: 39105247 [Abstract] [Full Text] [Related]
6. Red blood cell extended antigen typing in Omani patients with sickle cell disease to enhance daily transfusion practice. Breiki ASA, Kindi SA, Castilho L. Immunohematology; 2024 Sep 01; 40(3):93-99. PubMed ID: 39373300 [Abstract] [Full Text] [Related]
7. Predictors of red cell alloimmunization in multitransfused Egyptian patients with β-thalassemia. Hussein E, Ahmed Eldesoukey N, Rihan A, Kamal A. Arch Pathol Lab Med; 2014 May 01; 138(5):684-8. PubMed ID: 24786127 [Abstract] [Full Text] [Related]
8. RH genotypes and red cell alloimmunization rates in chronically transfused patients with sickle cell disease: A multisite study in the USA. Israelyan N, Vege S, Friedman DF, Zhang Z, Uter S, Fasano RM, Yee M, Piccone C, Kelly S, Hankins JS, Zheng Y, Westhoff CM, Chou ST. Transfusion; 2024 Mar 01; 64(3):526-535. PubMed ID: 38289184 [Abstract] [Full Text] [Related]
9. Red blood cell alloimmunization in sickle cell disease: prevalence in 2010. Miller ST, Kim HY, Weiner DL, Wager CG, Gallagher D, Styles LA, Dampier CD, Roseff SD, Investigators of the Sickle Cell Disease Clinical Research Network (SCDCRN). Transfusion; 2013 Apr 01; 53(4):704-9. PubMed ID: 22804353 [Abstract] [Full Text] [Related]
10. Comparative study of alloimmunization against red cell antigens in sickle cell disease & thalassaemia major patients on regular red cell transfusion. Jariwala K, Mishra K, Ghosh K. Indian J Med Res; 2019 Jan 01; 149(1):34-40. PubMed ID: 31115372 [Abstract] [Full Text] [Related]
11. How do I incorporate red cell genotyping to improve chronic transfusion therapy? Van Buren NL, Gorlin JB, Corby SM, Cassidy S, FritchLilla S, Nelson SC, Westhoff CM. Transfusion; 2020 Jan 01; 60(1):16-25. PubMed ID: 31758587 [Abstract] [Full Text] [Related]
12. Red blood cell alloimmunization in transfusion-dependent Egyptian patients with thalassemia in a limited donor exposure program. el-Danasoury AS, Eissa DG, Abdo RM, Elalfy MS. Transfusion; 2012 Jan 01; 52(1):43-7. PubMed ID: 21745214 [Abstract] [Full Text] [Related]
13. Impact of Red Blood Cell Antigen Matching on Alloimmunization and Transfusion Complications in Patients with Sickle Cell Disease: A Systematic Review. Fasano RM, Meyer EK, Branscomb J, White MS, Gibson RW, Eckman JR. Transfus Med Rev; 2019 Jan 01; 33(1):12-23. PubMed ID: 30122266 [Abstract] [Full Text] [Related]
14. Red Blood Cell Antigen Genotyping for Sickle Cell Disease, Thalassemia, and Other Transfusion Complications. Fasano RM, Chou ST. Transfus Med Rev; 2016 Oct 01; 30(4):197-201. PubMed ID: 27345938 [Abstract] [Full Text] [Related]
15. [Sickle cell anemia and transfusion safety in Bamako, Mali. Seroprevalence of HIV, HBV and HCV infections and alloimmunization belonged to Rh and Kell systems in sickle cell anemia patients]. Diarra AB, Guindo A, Kouriba B, Dorie A, Diabaté DT, Diawara SI, Fané B, Touré BA, Traoré A, Gulbis B, Diallo DA. Transfus Clin Biol; 2013 Dec 01; 20(5-6):476-81. PubMed ID: 23916574 [Abstract] [Full Text] [Related]
16. [Transfusion and alloimmunization in sickle cell anemia patients]. Norol F, Nadjahi J, Bachir D, Desaint C, Guillou Bataille M, Beaujean F, Bierling P, Bonin P, Galacteros F, Duedari N. Transfus Clin Biol; 1994 Dec 01; 1(1):27-34. PubMed ID: 8186850 [Abstract] [Full Text] [Related]
17. Prevalence of Red Blood Cell Alloimmunization Among Beta-Thalassemia and Sickle Cell Anemia Patients: a Study from Saudi Arabia. Felimban R, Alsharyufi A, Aljehani J, Sahlool A, Aljabri H, Qadah T. Clin Lab; 2021 Oct 01; 67(10):. PubMed ID: 34655200 [Abstract] [Full Text] [Related]
18. Risk factors for alloimmunization by patients with sickle cell disease. Murao M, Viana MB. Braz J Med Biol Res; 2005 May 01; 38(5):675-82. PubMed ID: 15917948 [Abstract] [Full Text] [Related]
19. Immune erythrocyte antibodies in adult patients with sickle cell disease and blood donors in Lagos, Nigeria: a comparative study. Adewoyin AS, Daramola OA, Ogbenna AA, Adeyemo TA. Immunohematology; 2021 Sep 01; 37(3):131-137. PubMed ID: 34591378 [Abstract] [Full Text] [Related]
20. Genomic analyses of RH alleles to improve transfusion therapy in patients with sickle cell disease. Reid ME, Halter Hipsky C, Hue-Roye K, Hoppe C. Blood Cells Mol Dis; 2014 Apr 01; 52(4):195-202. PubMed ID: 24309423 [Abstract] [Full Text] [Related] Page: [Next] [New Search]